Literature DB >> 28305696

Fertile heteroallelic combinations of mutant alleles of the otu locus of Drosophila melanogaster.

Patrick Daniel Storto1, Robert Charles King1.   

Abstract

This paper describes the ovarian pathologies observed when 108 different heteroallelic combinations were made involving 17 independent mutations at the ovarian tumor (otu) locus. Most of the mutant phenotypes can be explained as graded responses by individual germ cells to different levels of functionally active otu gene product (OGP) synthesized by the mutant cells themselves. The lowest and highest levels of OGP appear to be produced by otu 10 and otu 14, respectively. In most heteroallelic ovaries the alleles have additive effects, and hybrid germ cells reach a developmental stage more advanced than the "weaker" homozygote but less advanced than the "stronger" homozygote. However, examples of both positive and negative complementation also have been found, and these suggest that the products encoded by different mutant alleles can combine to form dimers or multimers which may be superior or inferior to the homodimers. In flies homozygous for otu 11 most ovarioles contain tumors, but some germ cells are able to develop further than those in otu 14 homozygotes. This suggests that, while otu 11 produces intermediate levels of OGP, it also produces a second product (which otu 14 cannot make) that is utilized at the period in oogenesis when development in cells homozygous for otu 14 is blocked. When otu 11 is combined with any one of eight specific alleles, it allows oocyte/nurse cell syncytia to differentiate that can complete development and undergo embryogenesis, if fertilized. The endopolyploid nurse cells of these hybrids have giant polytene chromosomes, and the presence of GPCs in functionally active, germ-line derived cells provides an interesting new system for experimental study. Analysis of the characteristic ovarian pathologies produced by flies of different genotypes leads to the conclusion that the products of the otu + gene are utilized during at least six different periods in Drosophila oogenesis.

Entities:  

Keywords:  Giant polytene chromosomes; Interallelic complementations; Oocyte/nurse cell syncytium; Ovarian tumor genes; Phenocritical threshold

Year:  1987        PMID: 28305696     DOI: 10.1007/BF00376345

Source DB:  PubMed          Journal:  Rouxs Arch Dev Biol        ISSN: 0930-035X


  5 in total

1.  Oogenesis in adult Drosophila melanogaster. IV. Hereditary ovarian tumors.

Authors:  R C KING; R G BURNETT; N A STALEY
Journal:  Growth       Date:  1957-12

2.  Complementation between alleles at the ovarian tumor locus of Drosophila melanogaster.

Authors:  R C King; D Mohler; S F Riley; P D Storto; P S Nicolazzo
Journal:  Dev Genet       Date:  1986

3.  Giant polytene chromosomes from the ovaries of a Drosophila mutant.

Authors:  R C King; S F Riley; J D Cassidy; P E White; Y K Paik
Journal:  Science       Date:  1981-04-24       Impact factor: 47.728

4.  Cytophotometric studies on cells from the ovaries of otu mutants of Drosophila melanogaster.

Authors:  E M Rasch; R C King; R W Rasch
Journal:  Histochemistry       Date:  1984

5.  Cytophotometric evidence for the transformation of oocytes into nurse cells in Drosophila melanogaster.

Authors:  R C King; E M Rasch; S F Riley; P M O'Grady; P D Storto
Journal:  Histochemistry       Date:  1985
  5 in total
  3 in total

1.  Polytene chromosomes from ovarian pseudonurse cells of the Drosophila melanogaster otu mutant. I. Photographic map of chromosome 3.

Authors:  T I Heino
Journal:  Chromosoma       Date:  1989-03       Impact factor: 4.316

2.  Effect of otu mutations on male fertility and spermatogenesis in Drosophila melanogaster.

Authors:  M Tirronen; T I Heino; Ch Roos
Journal:  Rouxs Arch Dev Biol       Date:  1993-05

3.  Tudor-domain containing protein 5-like promotes male sexual identity in the Drosophila germline and is repressed in females by Sex lethal.

Authors:  Shekerah Primus; Caitlin Pozmanter; Kelly Baxter; Mark Van Doren
Journal:  PLoS Genet       Date:  2019-07-22       Impact factor: 5.917

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.